The Effect of Posttherapy 131 I SPECT / CT on Risk Classification and Management of Patients with Differentiated Thyroid Cancer
暂无分享,去创建一个
S. Larson | M. Gonen | H. Strauss | H. Schöder | R. Tuttle | R. Grewal | J. Chou | J. Fox | S. Borkar
[1] Y. Nishiyama,et al. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] R. Tuttle,et al. Medical management of thyroid cancer: a risk adapted approach , 2008, Journal of surgical oncology.
[3] S. Balachandran,et al. Value of Thyroid Carcinoma Imaging After Therapeutic Doses of Radioiodine , 1981, Clinical nuclear medicine.
[4] W. Bautz,et al. Impact of 131I SPECT/Spiral CT on Nodal Staging of Differentiated Thyroid Carcinoma at the First Radioablation , 2008, Journal of Nuclear Medicine.
[5] M. Beheshti,et al. Posttherapeutic 131I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Stephanie L. Lee,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[7] Giuseppe Madeddu,et al. 131I SPECT/CT in the Follow-up of Differentiated Thyroid Carcinoma: Incremental Value Versus Planar Imaging , 2009, Journal of Nuclear Medicine.
[8] J. Němec,et al. Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] K. Frey,et al. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma. , 2008, AJR. American journal of roentgenology.
[10] N. Heutte,et al. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer. , 2009, The Journal of clinical endocrinology and metabolism.
[11] H. Amthauer,et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma , 2004, Nuclear medicine communications.
[12] W. Martin,et al. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[13] Quan-Yong Luo,et al. Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma , 2008, Journal of Nuclear Medicine.
[14] R. Tuttle. Risk-adapted management of thyroid cancer. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[15] Bruce Levin,et al. The Analysis of Data from Matched Samples , 2004 .
[16] S. Iwano,et al. Diagnostic Whole-Body Scanning Before Radioiodine Therapy for Pulmonary Metastases of Differentiated Thyroid Cancer: Predictive Value and Recommendations , 2008, Clinical nuclear medicine.